Matthieu Meryet‐Figuière

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers

Mohamad Moustafa Ali, Vijay Suresh Akhade, Subazini Thankaswamy Kosalai et al. · Nature Communications · 2018 · 120 citations · Full text

Medicine, Cancer Biology, Oncology +17

Bcl‐<scp>X_L</scp> and MCL‐1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis

Émilie Brotin, Matthieu Meryet‐Figuière, Karin Simonin et al. · International Journal of Cancer · 2009 · 112 citations

Medicine, Oncology, Pharmacology +17

miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation

Christophe Denoyelle, Bernard Lambert, Matthieu Meryet‐Figuière et al. · Cell Death and Disease · 2014 · 105 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy

Nicolas Vigneron, Matthieu Meryet‐Figuière, Audrey Guttin et al. · Molecular Oncology · 2016 · 84 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +17

Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy

Emilie Varin, Christophe Denoyelle, Émilie Brotin et al. · Carcinogenesis · 2010 · 74 citations

Medicine, Cell Biology, Oncology +17